NewsroomNewsroom
All News
2025-09-18Medinice signs letter of intent with CorNav Corporation
2025-09-01Medinice expects its latest PacePress® model to be approved for the European market in 2025
2025-08-26Medinice receives FDA feedback in the 510(k) process for CoolCryo
2025-08-19Medinice presents PacePress® clinical trial results on BIZNES24
2025-06-23CoolCryo FDA submission for cardiac cryoablation
2025-05-08Signing an agreement to finance the AtriClamp project- 2025-03-10Medinice S.A. obtains positive Interim Analysis results in the clinical trial of PacePress - early completion and a quick step towards certification
2024-12-03Breakthrough by Polish scientists saving heart disease patients
2024-10-16Agreement to subscribe to 1.2 million series M shares at 8 PLN each
2024-09-27Why are we issuing shares now? Medinice in PAP Business
2024-09-27Medinice's EGM on October 25, 2024, will vote on issuing up to 1.2 million shares to fund project commercialization
2024-08-21Talk: An Innovative Approach to Arrhythmia, Medinice in Biznes24.tv
2024-05-29Medinice is counting on five sales of completed projects - interview
2024-04-02From Concept to Clinical Application: How Innovations Are Developed in the Medical Sector
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.